BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6584198)

  • 1. Clinical and laboratory data related to maturation in acute leukemia.
    van Rhenen DJ; Langenhuijsen MM
    Cancer; 1984 May; 53(9):1923-6. PubMed ID: 6584198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: an analysis of 208 cases.
    Sexton C; Buss D; Powell B; O'Connor M; Rainer R; Woodruff R; Cruz J; Pettenati M; Rao PN; Case LD
    Leuk Res; 1996 Jun; 20(6):467-72. PubMed ID: 8709618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukaemia of adults in Auckland: biological characteristics and survival.
    Buchanan JG; Bensley KE
    N Z Med J; 1969 Jul; 70(446):1-6. PubMed ID: 5258863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain results of discussion concerning classification of acute leukemia].
    Lorie IuI
    Probl Gematol Pereliv Krovi; 1974 Mar; 19(3):6-10. PubMed ID: 4524749
    [No Abstract]   [Full Text] [Related]  

  • 5. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification of leukemias].
    Krepler P
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(1):24-9. PubMed ID: 4143640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute leukemia. Case material and therapeutic results].
    Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
    Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
    Davey FR; Erber WN; Gatter KC; Mason DY
    Am J Clin Pathol; 1988 Jan; 89(1):76-80. PubMed ID: 3422117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
    del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
    Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    Br J Haematol; 1976 Aug; 33(4):451-8. PubMed ID: 188440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia].
    Wang D; Ke XY; Wang J; Xu F; Hu YF
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1384-8. PubMed ID: 17785057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    Ann Intern Med; 1985 Oct; 103(4):620-5. PubMed ID: 3862359
    [No Abstract]   [Full Text] [Related]  

  • 15. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoblastic (M5a) form of relapse in acute myeloblastic (M2) leukemia with t(8;21)].
    Daniel MT; Bernheim A; Garand R; Bray B; Leverger G; Flandrin G; Berger R
    Nouv Rev Fr Hematol (1978); 1986; 28(2):115-7. PubMed ID: 3461425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7.
    Peterson BA; Levine EG
    Semin Oncol; 1987 Dec; 14(4):425-34. PubMed ID: 3321447
    [No Abstract]   [Full Text] [Related]  

  • 19. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell markers in the recognition of acute myeloblastic leukaemia subtypes.
    Andoljsek D; Preloznik Zupan I; Zontar D; Cernelc P; Mlakar U; Modic M; Pretnar J; Zver S
    Cell Mol Biol Lett; 2002; 7(2):343-5. PubMed ID: 12097981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.